Clinical Trial Update: Combination of Cryosurgery and NK Immunotherapy for Tumors in Transplanted Liver [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating the combination of cryosurgery and NK cell immunotherapy for liver tumors in patients with liver transplantation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Transplantation
• Liver Tumor

Drugs mentioned

• Cryosurgery
• NK immunotherapy (natural killer cell-based immunotherapy)

Snippet

Sponsor: Fuda Cancer Hospital, Guangzhou | Conditions: Liver Tumor, Evidence of Liver Transplantation | Phase 1, Phase 2 | Status: COMPLETED